Medifast (MED) Gross Profit (2010 - 2026)

Medifast's Gross Profit history runs 17 years deep, the most recent figure standing at $51.8 million for Q1 2026.

• Quarterly Gross Profit fell 38.56% year-over-year to $51.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $242.7 million (down 39.56% YoY) and the FY2025 annual result came in at $275.2 million, down 38.11% from the prior year.
• Gross Profit was $51.8 million for Q1 2026 at Medifast, down from $52.1 million in the prior quarter.
• Across five years, Gross Profit topped out at $321.7 million in Q2 2022 and bottomed at $51.8 million in Q1 2026.
• A 5-year average of $158.1 million and a median of $127.3 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit increased 21.62% — and 2024, when it tumbled 48.34%.
• Medifast's Gross Profit stood at $233.6 million in 2022, then tumbled by 39.48% to $141.4 million in 2023, then slumped by 37.6% to $88.2 million in 2024, then tumbled by 40.9% to $52.1 million in 2025, then dropped by 0.74% to $51.8 million in 2026.
• Business Quant data shows MED's Gross Profit at $51.8 million in Q1 2026, $52.1 million in Q4 2025, and $62.2 million in Q3 2025.